View of Predictive Factors of Secukinumab Response in Korean Hidradenitis Suppurativa Patients: Insights from a 48-Week Trial

Return to Article Details Predictive Factors of Secukinumab Response in Korean Hidradenitis Suppurativa Patients: Insights from a 48-Week Trial Download Download PDF